Cardiovascular Journal of Africa: Vol 29 No 6 (November/December 2018)

71 / 74

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 29, No 6, November/December 2018 AFRICA 403
Cardiovasc J Afr 2008; 19: 145–151.
44. Subbaiah M, Sharma V, Kumar S, Rajeshwari S, Kothari SS, Roy KK,
et al. Heart disease in pregnancy: cardiac and obstetric outcomes. Arch
Gynecol Obstet 2013; 288: 23–27.
45. Steinberg ZL, Dominguez-Islas CP, Otto CM, Stout KK, Krieger EV.
Maternal and fetal outcomes of anticoagulation in pregnant women
with mechanical heart valves. J Am Coll Cardiol 2017; 69: 2681–2691.
46. Van Hagen IM, Roos-Hesselink JW, Ruys TP, Merz WM, Goland S,
Gabriel H, et al., ERPT Investigators. Pregnancy in women with a
mechanical heart valve: Data of the European Society of Cardiology
Registry of Pregnancy and Cardiac Disease (ROPAC). Circulation 2015;
132: 132–142.
47. Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, Cifkova R,
Ferreira R, Foidart JM, et al., Task Force on the Management of
Cardiovascular Diseases during Pregnancy of the European Society of
Cardiology (ESC). ESC guidelines on the management of cardiovascu-
lar diseases during pregnancy. Eur Heart J 2011; 32: 3147–3197.
48. Heuvelman HJ, Arabkhani B, Cornette JM, Pieper PG, Bogers AJ,
Takkenberg JJ, Roos-Hesselink JW. Pregnancy outcomes in women with
aortic valve substitutes. Am J Cardiol 2013; 111: 382–387.
49. Arabkhani B, Heuvelman HJ, Bogers AJ, Mokhles MM, Roos-Hesselink
JW, Takkenberg JJ. Does pregnancy influence the durability of human
aortic valve substitutes? J Am Coll Cardiol 2012; 60: 1991–1992.
50. Zuhlke L, Acquah L. Pre-conception counselling for key cardiovascular
conditions in Africa: optimising pregnancy outcomes. Cardiovasc J Afr
2016; 27: 79–83.
51. Moghbeli N, Herrmann H. Mitral stenosis. Contemporary cardiology:
Valvular Heart Dis 2009; 4: 207–219.
52. Roos-Hesselink JW, Cornette J, Sliwa K, Pieper PG, Veldtman GR,
Johnson MR. Contraception and cardiovascular disease. Eur Heart J
2015; 36: 1728–1734, 34a–34b.
53. Hugon-Rodin J, Gompel A, Plu-Bureau G. Epidemiology of hormonal
contraceptives-related venous thromboembolism. Eur J Endocrinol
2014; 171: R221–230.
54. Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N.
Thrombotic stroke and myocardial infarction with hormonal contracep-
tion. New Engl J Med 2012; 366: 2257–2266.
55. Costescu DJ. Levonorgestrel-releasing intrauterine systems for long-
acting contraception: current perspectives, safety, and patient coun-
seling. Int J Women’s Health 2016; 8: 589–598.
56. Ghandi M, Martin S. Cardiac disease in pregnancy. S Austr Perinatal
Pract Guidelines 2014; 42: 1–28.
57. Westhoff-Bleck M, Podewski E, Hilfiker A, Hilfiker-Kleiner D.
Cardiovascular disorders in pregnancy: diagnosis and management.
Best Pract Res Clin Obstet Gynaecol 2013; 27: 821–834.
58. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC,
et al. Cardiac disease in pregnancy I. Prospective multicenter study of
pregnancy outcomes in women with heart disease. Circulation 2001;
104: 515–521.
59. Mocumbi AO, Sliwa K, Soma-Pillay P. Medical disease as a cause for
maternal mortality: the pre-imminence of cardiovascular pathology.
Cardiovasc J Afr 2016; 27(2): 84–88.
60. Pinder AJ, Dresner M, Calow C, Shorten GD, O’Riordan J, Johnson R.
Haemodynamic changes caused by oxytocin during caesarean section
under spinal anaesthesia. Int J Obstet Anesth 2002; 11: 156–159.
61. Thomas JS, Koh SH, Cooper GM. Haemodynamic effects of oxytocin
given as i.v. bolus or infusion on women undergoing Caesarean section.
Br J Anaesth 2007; 98: 116–119.
62. Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et
al. Guidelines on the prevention, diagnosis, and treatment of infective
endocarditis (new version 2009): the Task Force on the Prevention,
Diagnosis, and Treatment of Infective Endocarditis of the European
Society of Cardiology (ESC). Endorsed by the European Society of
Clinical Microbiology and Infectious Diseases (ESCMID) and the
International Society of Chemotherapy (ISC) for Infection and Cancer.
Eur Heart J 2009; 30: 2369–2413.
63. You D, Hug L, Anthony D. UNICEF report. Generation 2030. Africa
calls upon investing in and empowering girls and young women. Reprod
Health 2015; 12: 18.
64. United Nations. Transforming our world: the 2030 Agenda for
Sustainable Development. Geneva 2015.
65. Bundy D. Rethinking school health: A key component of education for
all. The International Bank for Reconstruction and Development. The
World Bank Group. 2011.
66. Mheta D. Health system factors that impact on access to maternal
services for women with disabilities in Sub-Saharan Africa: A systematic
review. Unpublished thesis. Univesity of Cape Town, 2015.
67. Shaw D. Sexual and reproductive health: rights and responsibilities.
Lancet 2006; 368: 1941–1943.
68. Fathalla MF, Sinding SW, Rosenfield A, Fathalla MM. Sexual and
reproductive health for all: a call for action. Lancet 2006; 368: 2095–
2100.
69. Cleland J, Bernstein S, Ezeh A, Faundes A, Glasier A, Innis J. Family
planning: the unfinished agenda. Lancet 2006; 368: 1810–1827.